Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06117683

Non-inferiority Trial Between Sotair® Device Attached to Manual Resuscitator Versus Mechanical Ventilation

Non-inferiority Comparative Trial Between Sotair® Device Attached to Manual Resuscitator Versus Mechanical Ventilation in Patients Undergoing Non-emergent Surgery With General Anesthesia

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
310 (estimated)
Sponsor
Rhode Island Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Effective respiratory ventilation is achieved by moving the right amount of air in and out of the lungs while keeping the pressures at a safe level. A disposable safety device, Adult Sotair®, was created to improve manual ventilation delivery. In this non-inferiority study, we will perform a pre-post study design (single group, within-group comparison) to test the non-inferiority of the Adult Sotair® device compared to mechanical ventilation.

Detailed description

Poor manual ventilation technique is a well-documented problem which occurs irrespective of a provider's qualifications or experience. A disposable safety device, Adult Sotair®, was created to improve manual ventilation delivery among providers. The device is attached to a bag valve mask (i.e. manual resuscitator) and employs a flow limiting valve mechanism to minimize excessive pressure in the airway system without venting air by capping peak flow rates at 55 L/min. For an average adult with normal lung compliance and resistance, this corresponds to a maximum airway pressure of approximately 20 cmH2O which minimizes air entry into the stomach. In this non-inferiority study, a pre-post study design (single group, within-group comparison) to test the non-inferiority of the Adult Sotair® device compared to mechanical ventilation with respect to airway pressure.

Conditions

Interventions

TypeNameDescription
DEVICEADULT Sotair DeviceSotair® device employs a flow limiting and pressure control valve mechanism.

Timeline

Start date
2023-12-20
Primary completion
2025-06-30
Completion
2025-07-01
First posted
2023-11-07
Last updated
2025-07-11

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06117683. Inclusion in this directory is not an endorsement.